Ftse Mib
33.067,99
-0,30%
DAX
19.261,75
-0,22%
S&P 500
5.999,82
-0,36%
NASDAQ
19.062,71
-0,59%
Bitcoin
96.803,52
5,25%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enliven Therapeutics Inc (ELVN) Enliven Therapeutics Inc (ELVN) Notizie

Enliven Therapeutics Inc

ELVN
24,74
0,39 (1,60%)
Ultimo aggiornamento: 20:47:19
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202422:35EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:28EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:48EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202423:55EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
13/11/202422:05PRNUSEnliven Therapeutics Reports Third Quarter Financial Results..
07/11/202422:05PRNUSEnliven Therapeutics to Present at the Jefferies London..
30/10/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202420:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
22/10/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/10/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/10/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/10/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/10/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202400:42EDGAR2Form 144 - Report of proposed sale of securities
18/10/202423:42EDGAR2Form 144 - Report of proposed sale of securities
18/10/202423:17EDGAR2Form 144 - Report of proposed sale of securities
18/10/202423:00EDGAR2Form 144 - Report of proposed sale of securities
18/10/202422:57EDGAR2Form 144 - Report of proposed sale of securities
11/10/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202402:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202402:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202422:27EDGAR2Form 144 - Report of proposed sale of securities
09/10/202422:16EDGAR2Form 144 - Report of proposed sale of securities
09/10/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/10/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202421:59EDGAR2Form 144 - Report of proposed sale of securities
04/10/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:14EDGAR2Form 144 - Report of proposed sale of securities
30/9/202422:19EDGAR2Form 144 - Report of proposed sale of securities
28/9/202415:35GLOBEEnliven Therapeutics Announces Positive Data Update from..
18/9/202422:05GLOBEEnliven Therapeutics Announces Details Regarding the..
03/9/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202422:32EDGAR2Form 144 - Report of proposed sale of securities
19/8/202422:32EDGAR2Form 144 - Report of proposed sale of securities
13/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:10EDGAR2Form 8-K - Current report
13/8/202422:05GLOBEEnliven Therapeutics Reports Second Quarter Financial..
03/8/202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202401:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202401:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 24,45 Min: 24,45 Max: 25,67
Chiusura: 24,35

La tua Cronologia

NASDAQ
ELVN
Enliven Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network